Prostate Knowledge Archive

Studies reveal that lycopene, a nutrient found in tomatoes, does not seem to reduce prostate cancer risk.

Historically, the answer has been yes, but mounting evidence suggests that lifestyle factors may influence risk.

A British study finds that repeat biopsies may play an important role in active surveillance for untreated, localized prostate cancer.

Anxiety, not clinical symptoms and disease progression, may sway patients toward treatment.

Blood and tissue levels of chromogranin A (CgA) may be early indication that prostate cancer that won’t respond for long to hormone therapy.

Study finds that finasteride may actually lower the overall risk of prostate cancer and aid in the detection of aggressive tumors. An earlier study had implicated finasteride in the development of these deadlier tumors.

A

More research is needed, but taking tadalafil (Cialis) could be helpful for men with BPH.

Researchers have identified several genetic variations that raise prostate cancer risk, variations that may also account for the higher incidence of prostate cancer in African Americans.

Researchers at Johns Hopkins University School of Medicine have developed a new blood test for prostate cancer, which in a preliminary study proved better than the PSA test at identifying which men have cancer. The new test measures levels of the protein EPCA-2, which — unlike PSA — is produced almost exclusively by cancerous tissue.